RankingsPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Common stock and paid-in capital

Sumitomo Pharma Co., Ltd.【JP:4506】

Market cap
¥1.16T
P/E ratio
12.6x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCommon stock and paid-in capital (Million JPY)YoY (%)
Mar 31, 202560,661+0.00%
Mar 31, 202460,661+0.00%
Mar 31, 202360,661-21.61%
Mar 31, 202277,386+1.14%
Mar 31, 202176,516-2.52%
Mar 31, 202078,498+2.58%
Mar 31, 201976,522+0.00%
Mar 31, 201876,520+99.99%
Mar 31, 201738,261+0.00%
Mar 31, 201638,260+0.00%
Mar 31, 201538,260

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)